In the present study, we have investigated whether changes in vascular reactivity in congestive heart failure (CHF) patients can be detected in the cutaneous microvessels and whether these changes are due to endothelial dysfunction, are affected by increasing age and related to an ongoing inflammation. The responses to local warming and iontophoretically administered endotheliumdependent and -independent vasodilators were investigated in healthy young adults, healthy elderly adults and elderly adults with CHF. The results were correlated with plasma concentrations of vascular risk factors and markers for endothelial dysfunction and inflammation. The vasorelaxant responses were reduced in the elderly groups and were attenuated further in the CHF group. This group also had increases in levels of several markers associated with inflammation, higher blood glucose and homocysteine levels, a lower low-density lipoprotein-cholesterol and a rise in the concentration of von Willebrand factor, indicating a prothrombotic endothelial function. The severity of the heart failure, measured as the plasma level of brain natriuretic peptide, correlated with the intensity of inflammation and to the changes in vascular risk factors and endothelial function. It is concluded that the reactivity of the cutaneous microvessels is reduced with age, and the presence of CHF causes a further impairment. There is endothelial dysfunction in CHF, but it is uncertain to what extent this contributes to the reduced vasodilatory capacity. The inflammatory response appears central for many of the manifestations of the CHF syndrome.
INTRODUCTION
Congestive heart failure (CHF) is a clinical syndrome characterized by a recognizable pattern of haemodynamic, renal, hormonal and neural responses [1] . Several of the compensatory mechanisms affect the peripheral circulation. A common finding is that the vasodilatory response to increased metabolic demands and vasorelaxing autacoids is reduced. Since the vasorelaxant capacity is important for the control of tissue perfusion, an impairment could contribute to several of the patient's symptoms, such as exaggerated muscle hypoxia during exercise. When these abnormalities affect the coronary circulation, they can further augment the myocardial damage. Furthermore, the total peripheral vascular resistance will tend to rise, thus increasing the workload of the heart [2] . It has been proposed that the impaired vasodilation is mainly due to a change in the functional mode of the endothelium, with a reduction in local concentrations of endothelium-derived vasodilators such as nitric oxide (NO), adenosine or endothelium-derived hyperpolarizing factor (EDHF) [3] [4] [5] . This has been denoted as endothelial dysfunction (EDF). Inflammation can induce EDF [6] , possibly by enhancing the production of reactive oxygen species (ROS), which can scavenge NO [7] . In CHF, the plasma levels of some pro-inflammatory mediators are elevated, indicating a low-grade inflammatory reaction [4] . It has thus been hypothesized that EDF is a part of the CHF syndrome and secondary to inflammation [3, 4] . There are, however, contradictory data, which suggest that the reduced vasodilatory capacity is attributed to nonendothelial factors such as an increased vasoconstrictive tone at rest or to changes in vascular smooth muscle function 'vascular stiffness' [8] .
It has been postulated that there are two principal modes of endothelial behaviour [9] . First, in its normal 'antithrombotic' state, the endothelium mediates vasodilation, prevents platelet adhesion and activation, and blocks thrombin formation. Adhesion and transmigration of leucocytes are attenuated and ROS are effectively scavenged. Secondly, when the endothelium is disturbed, for example by inflammation, completely opposite actions occur. In this dysfunctional state, there is vasoconstriction, increased endothelial production of von Willebrand factor (vWf), plasminogen activator inhibitor-1 (PAI-1), ROS and various adhesion molecules. This is thus a wider meaning of the term EDF. Reports of an elevated risk for thromboembolic events suggest that the endothelium could be in this 'prothrombotic state' in CHF [10] .
There are several methods to quantify endotheliumdependent vasodilation [11] . The most common is the invasive forearm technique where blood flow changes are measured by venous occlusion plethysmography after challenge with endothelium-dependent and -independent dilators. In the present study, we investigated if a noninvasive technique could be suitable for studies in this area instead: blood flow changes were induced by local iontophoretic administration of vasodilator drugs to the skin. We measured if the vasodilatory responses in this vascular bed were reduced in CHF and if this was due to EDF. Furthermore, we wanted to examine if there is a correlation between changes in vascular function, inflammatory activity, severity of CHF and prothrombotic activity. Since the vasodilatory capacity is reported to decline with increasing age [12] , we also wanted to study the influence of this parameter.
MATERIALS AND METHODS

Ethics
The investigation conforms with the principles outlined in the Declaration of Helsinki. The Ethics Committee 
Subjects
Studies were performed on three groups. Group 1: 15 patients (ten men and five women) treated at Lund University Hospital for CHF. They had a reduced left ventricular function upon echocardiography and elevated plasma levels of brain natriuretic peptide (BNP). Patients with diabetes mellitus, uraemia, medication with longacting nitrates, oxygen treatment, ongoing infection, dementia, active smoking habit or the presence of tremor were excluded. Two patients were judged to be in New York Heart Association functional class II, twelve in class III and one in class IV. Five patients had atrial fibrillation, one had a pacemaker and the remainder had sinus rhythm.
The assessed causes of CHF in these patients are given in Table 1 . Group 2: healthy age-and gender-matched controls to group 1. These subjects were not allowed to have clinical signs of CHF or plasma levels of BNP exceeding 25 pmol/l. In this group, one male subject was excluded because of elevated BNP. Group 3: in order to study the influence of age on vascular reactivity, six healthy young adults (three women and three men) were also studied. No blood samples were taken from this group of subjects. Basal characteristics for the subjects are given in Table 2 .
Pharmacological treatment
At the time of the study, all of the patients were treated with diuretics. In addition, seven patients were on medication with digitalis, two were taking calcium channel blockers, eight were taking angiotensin-converting-enzyme (ACE)-inhibitors, eight were taking β-adrenergic antagonists, seven were taking warfarin, three were taking allopurinol, two were taking statins, eight were taking salicylic acid, three received vitamin B 12 and two received folic acid. In the age-matched control group, two subjects were taking diuretics, three were taking β-adrenergic 
Quantification of vascular risk factors
The vascular risk factors homocysteine (Hcy), glucose, low-density lipoprotein (LDL)-cholesterol and highdensity lipoprotein-cholesterol were deemed likely to influence the vascular reactivity. The plasma levels were thus measured in the CHF patients and their controls.
Estimation of inflammatory and prothrombotic activity
As markers for inflammatory activity, we chose to quantify the plasma levels of C-reactive protein (CRP; high-sensitive method), interleukin (IL)-6, tumour necrosis factor α (TNFα), soluble IL-2 receptor (sIL-2r), IL-1β and IL-8.
CHF has been described as a hyperuricaemic condition [13] , and the serum uric acid levels have been found to strongly correlate with inflammatory activity [14] . Uric acid is thus regarded as a marker of chronic inflammation. vWf and PAI-1 were measured as markers for a prothrombotic state of the endothelium. vWf and PAI-1 concentrations were analysed at the Department of Clinical Chemistry, Malmo University Hospital, Malmo. All other blood samples were analysed at the Department of Clinical Chemistry, Lund University Hospital.
Blood flow measurements
Cutaneous blood flow was measured using the PeriFlux System 5000 (Perimed, Järfälla, Sweden). This method is non-invasive and gives minimal discomfort to the studied subject. Laser-generated light at a wavelength of 780 nm is directed to the skin using a fibre optic probe. The light reflected from moving blood cells in the superficial skin microvessels undergoes a shift in frequency (Doppler effect) that is proportional to the number and velocity of the moving blood cells. The laser Doppler output is semi-quantitative and we have presented all data as the percentage change compared with the baseline perfusion value. Temperature of the skin was recorded continuously. The ratio between blood pressure (mmHg) and the value for the local blood flow given by the Doppler output was calculated as an estimate of the basal cutaneous vascular resistance.
Iontophoresis
Constant current iontophoresis was used to enhance the perfusion of charged molecules into the skin of the dorsal side of the lower arm. Endothelium-dependent vasodilation was provoked by iontophoresis of the cation acetylcholine (ACh; 2 % dissolved in MilliQ water; Sigma, St. Louis, MO, U.S.A.) using anodal current. Endothelium-independent vasodilation was provoked by iontophoresis of the negatively charged NO donor sodium nitroprusside (SNP; 1 % in MilliQ water; Sigma) using cathodal current.
The PeriIont System (Perimed) used in this study contains an applicator with a small recess in the centre and circular temperature probe surrounding the application site. The recess in the centre allows the insertion of a fibre optic probe to measure the blood flow in the stimulated area. An additional temperature probe containing a fibre optic probe was placed at a distance suitable to avoid large veins. This was used as a reference during the iontophoresis and was subsequently used to determine the response to local warming.
Protocol
All studies were performed in a temperature-controlled room at 22-24
• C. All subjects were resting in the supine position. Blood pressure and heart rate were measured before and after stimulation, and the lowest value is given. The skin of the lower arm was gently cleaned with an alcohol swab and the iontophoretic applicators/fibre optic probes were applied to the forearm. The basal blood flow was studied for 2 min after which ACh was transferred by iontophoresis (anodal current, 0.2 mA for 20 s). The current alone did not affect the in blood flow (results not shown). Repeating the iontophoretic stimulation five times at 60 s intervals produced a stimuliresponse curve. Endothelium-independent vasodilation was studied by iontophoresis of SNP as above (cathodal current, 0.1 mA for 60 s). The stimulation was repeated four times at 60 s intervals. Finally, the response to heat was measured following local warming to + 44
• C for 10 min.
Statistical analysis
Statistical analysis was performed by Mann-Whitney U test when two groups were compared, or by Elderly CHF patients (n = 15) and age-matched controls (n = 14) had a mean age of 74 years, whereas young controls (n = 6) had a mean age of 23 years. Values for the changes in cutaneous blood flow are expressed as a percentage of the baseline and are means + − S.E.M. AUC values for elderly controls was statistically different from both young controls (P = 0.011) and CHF patients (P = 0.026) as determined by Kruskal-Wallis/Mann-Whitney tests.
Kruskal-Wallis test, followed by Mann-Whitney when there were more than two groups. For analysis of the stimuli-response curves an estimate for the area under the curve (AUC) was performed for each patient by adding the values for each stimulation. The resulting numbers were then used for the determination of statistical significance. This also reduced the random variability between different measurements [15] . Calculations were performed using StatView 5.0 (StatView, Berkeley, CA, U.S.A.).
RESULTS
Vascular reactivity
The estimated cutaneous vascular resistance did not differ significantly between the groups before stimulation ( Table 2 ). The vasodilatory response to ACh, measured as the AUC, was significantly higher in the young adults than in the healthy elderly controls (Figure 1 ). The AUC values (mean + − S.E.M.) were 3251 + − 456 for the elderly controls, 2002 + − 378 for the CHF patients and 6195 + − 887 for the young controls (P = 0.026 and P = 0.011 respectively, compared with elderly controls). Also, the response to SNP was higher in young compared with elderly controls, but the difference did not reach statistical significance. The effect of SNP was significantly attenuated in CHF patients compared with the agematched controls (Figure 2 ). Values were 2230 + − 397 for the elderly controls, 1187 + − 198 for the CHF patients (P = 0.02 compared with age-matched controls) and 3014 + − 384 for the young controls (not significant compared with elderly controls).
The response to heat was higher in the young adults compared with the elderly controls and CHF patients. There was no difference between the two elderly groups in this respect. The response to heat was greater in magnitude than the highest response following pharmacological stimulation (Figure 3) . The increase in blood flow following ACh, expressed as increase in the percentage of the response to heat, was 58.1 + − 12.0, 52.4 + − 9.7 and 56.4 + − 8.5 (no significant difference between groups) for the young healthy, elderly healthy and CHF groups respectively. Corresponding values for SNP were 36.5 + − 6.5, 42.8 + − 6.5 and 99.7 + − 37.9 (no significant difference between groups).
Plasma samples
The mean BNP level was approx. 20-fold higher in the CHF group compared with the age-matched controls (Table 2 ). In the CHF group, there were signs of a low-grade inflammation with elevated plasma levels of CRP, IL-6, sIL-2r and uric acid. The mean TNFα level was higher in patients, but the difference did not reach statistical significance. There was no marked change in IL-8 concentration, and the concentration of IL-1β did not reach detection level in any of the subjects studied. The changes in cytokine concentrations were relatively small, however, and only the sIL-2r level exceeded the range for normal variation set by the laboratory (Figure 4) . The vascular risk factor profile was changed in CHF patients with a higher (non-fasting) blood glucose There was a higher vWf concentration in CHF patients (2.8 + − 0.24 compared with 1.7 + − 0.15 international units/ml) indicating (prothrombotic) EDF. Also, the mean PAI-1 level was higher (7.7 + − 2.7 compared with 4.0 + − 1.0 international units/ml), but the difference did not reach statistical significance.
Correlations
The severity of CHF, measured as plasma BNP concentrations, was moderately correlated with several of the inflammatory markers, including IL-6, IL-8, CRP (r 0.5, P < 0.01) and uric acid (r = 0.6, P < 0.001). There was also a fair-to-moderate correlation between BNP and some vascular risk factors: β-glucose, Hcy (both r = 0.4, P < 0.05) and LDL-cholesterol (r = − 0.5, P < 0.01). The correlation with pulse rate was fair (r = 0.4, P < 0.05). There was no correlation with vascular reactivity, but a moderate correlation with plasma concentrations of vWf (r = 0.6, P < 0.001) and PAI-1 (r = 0.4, P < 0.05).
There was also fair-to-moderate correlation between inflammatory activity and the vascular risk factors. LDLcholesterol was inversely correlated with both uric acid and IL-6 (r = − 0.6, P < 0.01 and r = − 0.4, P < 0.05 respectively). Hcy positively correlated with IL-6, sIL2r and uric acid (r = 0.5, P < 0.01, r = 0.6, P < 0.001 and r = 0.5, P < 0.01 respectively) and negatively to basal vascular resistance and body mass index (BMI; both r = − 0.5, P < 0.05).
The prothrombotic factors vWf and PAI-1 exhibited a fair correlation with each other (r = 0.4, P < 0.05). Several of the inflammatory markers co-varied with the vWF concentration (IL-6 and sIL-2r, r = 0.5, P < 0.01; and sCRP, r = 0.4, P < 0.05). The corresponding value for Hcy was r = 0.4, P < 0.05). sCRP also correlated with the PAI-I levels (r = 0.6, P < 0.001).
In the elderly groups, BMI correlated both the cutaneous basal vascular resistance and mean arterial pressure (r = 0.6, P < 0.01). There was no clear correlation between mean arterial pressure and vascular resistance however.
A few of the parameters co-varied with the blood flow responses. The AUC for the response to ACh and the maximal response to heat correlated negatively with the concentration of sIL-2r (r = − 0.4, P < 0.05) and positively to LDL-cholesterol (r = 0.6, P < 0.001 and r = 0.4, P < 0.05 respectively). The AUC for both ACh and SNP was negatively correlated with vWF concentration (r = − 0.4, P < 0.05). The corresponding values for SNP correlated negatively with the CRP level (r = − 0.4, P < 0.05).
DISCUSSION
Blood flow measurements
To the best of our knowledge, this is the first time that a non-invasive method has been used for the study of vascular function in CHF patients. We correlated the blood flow responses in the cutaneous microvessels to inflammatory activity, aging and severity of CHF. The vasorelaxation following pharmacological stimulation and heat was greater in young adults than in elderly subjects; it can thus be concluded that the general vasodilatory capacity in the skin is reduced with advancing age. When the two elderly groups were compared, the responses to either vasodilator were lower in the CHF group. It seems likely that this may contribute to several of the patient's symptoms. The response to heat did not differ between the two elderly groups and its magnitude was higher than the response to SNP/ACh. This indicates that the maximal vasodilatory capacity was preserved in this group of CHF patients, but that there was a rightward shift in the dose-response curves for the pharmacological stimuli.
Both high age and the presence of CHF attenuated the responses to SNP and ACh to a similar extent. Thus our results do not support the hypothesis that the reduced vasorelaxing ability in CHF is secondary to EDF. Instead they suggest that the responsiveness of the contractile elements or the mechanisms directly regulating their tone was reduced. The responses to each of the pharmacological stimuli relative to the response of heat did not differ significantly for any of the groups, which gives further support to this view. It could still be, however, that the vasodilatory mechanisms of the endothelium are dysfunctional, but the changed action of the end organs makes this difficult to detect.
These results are consistent with the findings of Negrao et al. [8] , who suggested that the attenuated resting or reflex-mediated vascular vasodilation in CHF was due to heightened vasoconstrictor influences, such as increased sympathetic neural outflow, angiotensin and endothelin activity. The estimated values for basal vascular resistance at rest did not vary significantly in our population, however, indicating that, in this vascular bed, there is no significant vasoconstriction in any of the groups. Although our data should be interpreted with some caution, since the flow values are semi-quantitative and measurements were made on only a small fraction of the total cutaneous circulation, the results are supported by a similar finding in a study using the invasive forearm technique [16] . It thus raises some doubts as to whether the skin vessels in CHF patients are constricted at rest.
Another possible explanation for the reduced effect of SNP could be the presence of an abnormal endorgan response, i.e., a 'vascular stiffness' that makes blood vessels poorly responsive to vasodilator stimuli in general. One mechanism for this appears to be increased sodium content of the blood vessels [2] ; however, other factors such as cellular stress and hypoxia can inhibit vascular relaxation in reactions involving heat shock proteins [17] .
As mentioned above, several other reports in this area have, in contrast with our present observation, indicated the presence of EDF as the major cause for the impaired vasodilation. There are several possible explanations for the conflicting results. One is the difference in methodology. The method used in the present study is capable of detecting a selective reduction of endothelium-dependent vasodilation; this has been shown in several conditions such as children born with a low birth weight [18] and in heart transplant recipients [19] . In animal models of heart failure, however, it has been reported that endothelium-dependent relaxation is not uniformly impaired throughout the arterial bed [20] . The most commonly used method for this type of study [3, 4, 16] is the invasive forearm technique [11] , which gives values for the net vascular resistance in the skin and muscle. The portion of cardiac output that reaches the skeletal muscle at rest is approx. twice as much as that which reaches the skin [21] , and it could be that in CHF the vascular function in the skeletal muscle circulation differs from that of the skin. Another possible cause for the discrepancy could be differences in the study population. The patients in the present study were older than in most other studies and they were at an advanced stage of the disease. Bank et al. [16] observed in a study of CHF patients approx. 20 years younger than in our present study that EDF mainly influenced the blood flow in early stages of CHF syndrome but, similar to our results, the responses to both endothelium-dependent and -independent dilators were reduced at more advanced stages. Finally, pharmacological therapy could have affected the results. We did not attempt to discontinue any treatment, and it is known that argiotensin-converting-enzyme inhibitors improve endothelium-mediated vasodilation in patients with heart failure [22] .
CHF, inflammation and vascular reactivity
CHF was associated with an inflammatory reaction as indicated by the elevated levels of cytokines and sCRP. The increased levels of sIL-2r, which is a well-known marker for T-cell activation, suggests that the immune system could be one initiator of the response. The mean uric acid level was, as expected ( [13, 14] , and references therein), elevated by over 50 % in the CHF group and there was a weak, but significant, correlation between some inflammatory parameters (IL-6 and sIL-2r) and uric acid levels (results not shown). Both cytokines and the uric acid concentrations co-varied with the severity of CHF measured as plasma levels of BNP. These findings are in agreement with several other reports. For cytokines, one of the largest is a sub-study to the MERIT-HF trial [23] , where increases in TNFα and IL-8 were also reported. The elevation of these cytokines did not reach statistical significance in our study, most probably due to the smaller study size.
Interestingly the T-cell activation marker sIL-2r correlated positively with the reduction in endotheliumdependent vasodilation. Besides this, we could not detect any significant co-variation between inflammatory activity and the blood flow responses. This was somewhat unexpected, since the post-ischaemic vascular response in the leg has been reported to correlate to uric acid levels [13] and inflammation can induce EDF (see Introduction). Furthermore, several of the possible mechanisms that may induce hyperuricaemia could, on theoretical grounds, be expected to influence vascular reactivity. In the peripheral vasculature and the heart, the endothelial cells are the predominant site of xanthine oxidase (XO), the enzyme involved in uric acid production [13] . This makes it possible that, from a structural point of view, XO could be affecting vascular function. XO activity is stimulated by tissue hypoxia and this parameter is likely to be directly linked to the vasodilatory capacity and to co-vary with the severity of CHF [24] . Also, the inflammatory response could be expected to induce EDF through an XOmediated mechanism, since this enzyme contributes to ROS formation [13] and it can be induced by cytokines such as IL-6 and TNFα [25] . Thus we did expect a positive co-variation between uric acid levels and vascular reactivity, and our failure to detect this could possibly be due to a too small sample size or interference from factors that affect the uric acid levels, but do not affect the vascular function to a large extent. In our present study, the uric acid levels were reasonably correlated with serum creatinine (results not shown), and renal function could be one such parameter. Also, chronic diuretic therapy will raise uric acid concentrations [24] .
Vascular risk factors, CHF and blood flow
In the present study, we measured the levels of some well-known vascular risk factors that were expected to influence vascular reactivity. The mean LDL-cholesterol level was significantly lower in CHF patients than in age-matched controls. Our blood samples were obtained from non-fasting subjects and the results may have been influenced by an uneven distribution of nutritional intake. The mean level in the CHF group was even below the reference value for the laboratory, which supports the interpretation that the detected difference was real and a part of the disease. It has been shown previously [26] that the cholesterol concentration has a biological relevance for CHF syndrome, since a low value is associated with poor clinical outcome. The positive correlation between LDL levels and vascular reactivity was unexpected, since hypercholesterolaemia is known to induce EDF [4] . It seems reasonable to suggest that some upstream factor(s) affects both the vascular function and the LDL concentration. LDL-cholesterol is known to be a negative acute-phase reactant [27] and thus be initiated by the inflammatory reaction. In agreement with this, we found that the LDL concentration was negatively correlated with IL-6. The acute-phase reaction is also reported [28] to be associated with a change in LDL particle composition into a more atherogenic type, and it could be that this has more pronounced effects on vascular function than the naïve one.
Although patients with diabetes mellitus were excluded from the study, the mean blood glucose level was somewhat higher in the CHF group. This is likely to be due to an impaired glucose tolerance (IGT), which is a well-known characteristic of an inflammatory reaction or other forms of physical stress. IGT seems to be firmly associated with EDF [28] , but we could not detect any correlation between blood glucose values and vascular reactivity. This could be due to the fact that it is less likely that a single non-fasting glucose value will give a good estimate of the degree of IGT.
The higher mean Hcy values in the CHF group and the positive correlation between Hcy and BNP concentrations indicate that hyperhomocyst(e)inaemia is part of CHF syndrome. It has been suggested [29] that Hcy can initiate a cascade of inflammatory pathways acting on the vascular cells; however, the relationship between the acute-phase response and Hcy seems to be complicated, and Hcy levels have been reported [30] to have an almost inverse relation to the acute-phase response after myocardial infarction. Hcy is reported to have pronounced vascular effects and acute elevation of the plasma concentration has been shown to induce EDF [31] . We observed that Hcy was associated with the inflammatory reaction with a positive correlation with sIL-2r and IL-6 levels. Also, other factors could be involved: the positive correlation with plasma creatinine suggests that an impaired renal function could have contributed, and the negative correlation with BMI could indicate that the nutritional intake influenced the result. Hcy concentration co-varied with the basal vascular resistance, a finding of uncertain significance, but, besides this, we could not detect any correlation between the vascular reactivity and Hcy.
Prothrombotic endothelial function
CHF is an independent risk factor for thromboembolic disease [10] . Part of this could be explained by rheological factors: blood that flows slowly tends to clot. In our present study group, we also found that the endotheliumderived factor vWF was elevated in the CHF group and that this correlated with several of the inflammatory markers as well as to the severity of CHF measured as BNP. The association between the acute-phase response and the vWf activity has been known for a number of years [32] and it seems likely that the prothrombotic activity is secondary to the inflammatory response. We could thus detect an EDF (prothrombotic) with a reasonable correlation with the impairment of vascular reactivity. The data are thus in line with the hypothesis by Becker et al. [9] in which the endothelium behaves in two principal modes, but we could not detect a specific reduction in the endothelium-dependent vasodilator response, possibly due to the attenuation of the vascular smooth muscle function.
Conclusions
The present study shows that, with increasing age, reactivity in the cutaneous microvessels is attenuated. The presence of CHF causes further impairment, which, in our population, had a magnitude close to the effect of 50 years of aging. The reduction seemed to be caused by an impaired vascular smooth muscle function. CHF syndrome also induced an EDF as indicated by the elevated prothrombotic activity, but we could not with certainty detect a specific attenuation of endothelium-dependent vasodilation. A central part of CHF syndrome is a low-grade inflammation and this could induce secondary changes such as EDF, reduction in LDL-cholesterol, elevation of blood glucose and hyperuricaemia. The inflammation is associated with Tcell activation, and hyperhomocyst(e)inaemia may also be a possible contributing factor.
It can be concluded that it is possible to monitor microvascular function with this non-invasive technique. Further studies are required to determine the correlation between the changes in vascular reactivity, clinical symptoms and prognosis.
